JT

Jaya Chakravarty

Banaras Hindu University, Patna Medical College and Hospital, Royal College of Physicians

ORCID iD 0000-0001-9834-8053

About

I have been a faculty member at the Institute of Medical Sciences, Banaras Hindu University (IMS, BHU) since 2007 and a researcher in infectious diseases. I have played a pivotal role in transformative advances in kala-azar treatment, including the introduction of single-dose liposomal amphotericin B and multidrug therapy. These strategies were later adopted by the World Health Organization and India’s National Vector Borne Disease Control Programme, with findings published in The New England Journal of Medicine and The Lancet. I led India’s Phase I clinical trial of a leishmaniasis vaccine and has been a key leader in an NIH-sponsored research program for over 15 years.
As Program Director of the Centre of Excellence in HIV Care, I have implemented innovative interventions that significantly improved patient outcomes, including routine cryptococcal antigen
screening, HPV testing, and detection of antiretroviral resistance mutations in treatment failure.
During the COVID-19 pandemic, I served as Nodal Officer at BHU and chaired the COVID- associated fungal infections study group, leading research that advanced the understanding and management of COVID-19–associated mucormycosis.
I have authored >150 publications, with > 7,600 citations, h-index of 43.
I am a National AIDS clinical expert, and a member of the Technical Resource Group for the National AIDS Control Organization, and contributes to ICMR guideline development.
I am A Fellow of the Indian College of Physicians, Royal College of Physicians (London), and National Academy of Medical Sciences. I have
served as Head Department of Medicine (2018–2021), and have established the Division of Infectious Diseases.
I am expert member in many National programs and task force.

 Member of the task force of SERB-IRHPA National Biosafety Level-3 Facilities (BSL / ABSL 3) in 2022.  
 Member of the Screening Committee for “SERB-SUPRA” in 2021.
 National Expert Consultant of API for developing National Action Plan on Antimicrobial resistance AMR 2.0 in 2022.
 Expert consultant for IGNOU(2016) for development of PG Diploma in HIV Medicine
 Expert for Department of Health Research (DHR) and National Medical Commission (NMC) for identification of thesis topics for prospective postgraduate students 2023-2024.
 Expert for DHR & DG, ICMR and Directorate General of Health Services (DGHS), “Evidence-based antibiotic guidelines for various clinical conditions”, 2024 till date
 Member of  Technical Specification of ARV drugs ,2024 till date
 Expert member of NACEP (National AIDS Clinical Expert Panel ) 2024-till date
 Member of TRG (Technical Resource Group) for National AIDS Control organization- 2024-till date
 Member National AIDS Clinical Expert Panel, National AIDS Control organization-2025 till date
I have been closely associated with Association of Physicians of India, Clinical Infectious disease society f India, Association of Physicians of India, UP chapter & Varanasi Chapter. I have regularly contributed to Medicine update published by Association of Physicians of India since 2004. I have been invited to deliver lectures in many National and state conferences (APICON, UPAPICON, TROPICON, CIDSCON, HIV congress) and CME. I was the Organizing Secretary of the Annual Conference of Clinical Infectious Disease
Society of India, CIDSCON in 2016 and has been scientific secretary of UPAPICON 2018, 2007 and UPDACON 2013, Infectious Disease Update 2024. I am the founding executive member of UP chapter of
CIDS in 2025. I was also a Governing Body member of UP chapter of API from 2018-2024 and currently the Vice president of API Varanasi Chapter and Organizing Chairperson for UPAPICON 2026. I have guided/co-guided more than 30 post graduate and 10 PhD theses. I received the first clinician travel award by the American Society of Tropical Medicine and Hygiene in 2023.
I have regularly imparted public awareness program in HIV, tuberculosis, Antimicrobial resistance and held screening camps in nearby villages on non communicable diseases like diabetes and hypertension.

Employment

  • Banaras Hindu University Professor
    2017 - Present
  • Banaras Hindu University Associate Professor
    2014 - 2017
  • Banaras Hindu University Assistant Professor
    2007 - 2014

Education

  • Patna Medical College and Hospital MD
    1998 - 2001
  • Patna Medical College and Hospital MBBS
    1989 - 1995
  • Royal College of Physicians DTMH

Projects & Funding

Projects & funding information is unavailable.

Publications (164)

  • Skin pharmacokinetics and pharmacodynamics in patients with post-kala-azar dermal leishmaniasis
    International Journal of Antimicrobial Agents 2026
    +Save
  • Comparative clinical profile of herpes zoster in immunocompromised and immunocompetent patients: insights from a tertiary care center
    MGM Journal of Medical Sciences 2025
    +Save
  • Comparison of different methods for the detection of HLA-B* 57: 01 allele in people living with HIV in Eastern Uttar Pradesh, India
    BMC Infectious Diseases 2025
    +Save
  • Metronidazole-induced cerebellar dysfunction: An underdiagnosed identity
    Journal of Family Medicine and Primary Care 2025
    +Save
  • Neurological manifestations and neuropharmacology of HIV/AIDS
    Neuropsychiatric Complications of HIV 2025
    +Save
  • The Leishmaniasis
    Nature Reviews Disease Primers 2025
    +Save
  • Visceral leishmaniasis: Recent updates
    Annals of Medical Science & Research 2025
    +Save
  • Recent Advances in the Treatment of Leishmaniasis
    Pediatric Infectious Disease Journal 2024 DOI: 10.1097/INF.0000000000004429
    +Save
  • A phase II, non-comparative randomised trial of two treatments involving liposomal amphotericin B and miltefosine for post-kala-azar dermal leishmaniasis in India and Bangladesh
    PLOS Neglected Tropical Diseases 2024
    +Save
  • Amphotericin B Deoxycholate Treatment of Post--Kala-Azar Dermal Leishmaniasis in India
    The American Journal of Tropical Medicine and Hygiene 2024
    +Save